| Literature DB >> 35014702 |
Ilya Okunev1, Eric P Tranby2, Matt Jacob3, Vuong K Diep4, Abigail Kelly5, Lisa J Heaton2, Julie Frantsve-Hawley6.
Abstract
OBJECTIVE: To ascertain the financial impact associated with the underutilization of preventive dental care for adults enrolled in Medicaid.Entities:
Keywords: dental costs; dental utilization; dentistry; preventive dentistry
Mesh:
Substances:
Year: 2022 PMID: 35014702 PMCID: PMC9303757 DOI: 10.1111/jphd.12494
Source DB: PubMed Journal: J Public Health Dent ISSN: 0022-4006 Impact factor: 2.258
FIGURE 1Selection criteria for the study population. This figure shows the selection criteria for our study population. Years prevention is based on the number of years in the lookback period that a patient received a preventive service [Color figure can be viewed at wileyonlinelibrary.com]
Summary statistics of study population
| Years prevention | Total | ||||||
|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | ||
| Patients | 65,516 (35%) | 33,210 (18%) | 26,137 (14%) | 21,685 (12%) | 19,298 (10%) | 19,756 (11%) | 185,602 (100%) |
| Sex | |||||||
| Male | 22,044 (34%) | 9733 (29%) | 7687 (29%) | 6742 (31%) | 6327 (33%) | 7334 (37%) | 59,867 (32%) |
| Female | 43,472 (66%) | 23,477 (71%) | 18,450 (71%) | 14,943 (69%) | 12,971 (67%) | 12,422 (63%) | 125,735 (68%) |
| Race | |||||||
| White | 35,080 (54%) | 18,945 (57%) | 15,393 (59%) | 13,175 (61%) | 12,336 (64%) | 13,396 (68%) | 108,325 (58%) |
| Black | 23,634 (36%) | 10,994 (33%) | 8032 (31%) | 6267 (29%) | 4967 (26%) | 4423 (22%) | 58,317 (31%) |
| Hispanic | 1132 (2%) | 904 (3%) | 814 (3%) | 690 (3%) | 634 (3%) | 610 (3%) | 4784 (3%) |
| Other | 5670 (8%) | 1767 (7%) | 1898 (7%) | 1553 (7%) | 1361 (7%) | 1327 (7%) | 14,176 (8%) |
| Age group | |||||||
| 21–30 | 10,041 (15%) | 7864 (24%) | 6281 (24%) | 5135 (24%) | 4176 (22%) | 3974 (20%) | 37,471 (20%) |
| 31–40 | 16,084 (25%) | 9462 (28%) | 7492 (29%) | 5886 (27%) | 5034 (26%) | 4738 (24%) | 48,696 (26%) |
| 41–50 | 13,947 (21%) | 6850 (21%) | 5463 (21%) | 4686 (22%) | 4315 (22%) | 4534 (23%) | 39,795 (21%) |
| 51–64 | 25,444 (39%) | 9034 (27%) | 6901 (26%) | 5978 (28%) | 5773 (30%) | 6510 (33%) | 59,640 (32%) |
Note: Percentages are all row percentages with the exception of the Total column, where percentages are column percentages.
Average dental cost savings of preventive dental care: Total and by sex, race, and age
| 1 year prevention | 2 years prevention | 3 years prevention | 4 years prevention | 5 years prevention | |
|---|---|---|---|---|---|
| All patients | $46.73 (10%) | $82.04 (18%) | $131.39 (28%) | $169.6 (37%) | $200.86 (43%) |
| Sex | |||||
| Male | $67.96 (14%) | $114.15 (23%) | $172.65 (35%) | $208.69 (43%) | $239.35 (49%) |
| Female | $35.77 (8%) | $66.77 (15%) | $112.1 (25%) | $150.26 (33%) | $180.14 (40%) |
| Race | |||||
| White | $68.15 (13%) | $113.71 (22%) | $170.83 (34%) | $215.14 (42%) | $251.09 (49%) |
| Black | $31.58 (8%) | $48.39 (12%) | $88.9 (22%) | $105.54 (27%) | $115.86 (29%) |
| Hispanic | $118.01 (26%) | $80.97 (18%) | $74.71 (17%) | $131.04 (29%) | $161.25 (36%) |
| Other | $32.34 (7%) | $107.81 (24%) | $117.87 (26%) | $197.34 (44%) | $194.84 (43%) |
| Age group | |||||
| 21–30 | $11.97 (3%) | $43.31 (10%) | $95.48 (23%) | $121.17 (29%) | $157.23 (38%) |
| 31–40 | $44.8 (10%) | $72.94 (16%) | $127.48 (28%) | $177.56 (39%) | $211.4 (47%) |
| 41–50 | $68.36 (14%) | $110.08 (22%) | $147.18 (30%) | $194.4 (40%) | $239.05 (49%) |
| 51–64 | $41.26 (9%) | $82.27 (17%) | $134.17 (28%) | $165.86 (35%) | $184.31 (39%) |
Note: This table calculates the savings as seen in our study population of dental costs in the measurement year as compared with individuals that no preventive care in the lookback period.
Model on total dental costs during the measurement year 2019
| Parameter | Estimate | Standard error |
|
| Predicted cost | Lower CI of predicted cost | Upper CI of predicted cost |
|---|---|---|---|---|---|---|---|
| Intercept | 5.8732 | 0.0204 | 288.24 | <0.0001 | |||
| Years prevention | |||||||
| 0 years | 0.4959 | 0.0108 | 45.75 | <0.0001 | 481.55 | 471.77 | 491.53 |
| 1 year | 0.3672 | 0.0118 | 31.19 | <0.0001 | 423.41 | 413.82 | 433.24 |
| 2 years | 0.2924 | 0.0126 | 23.25 | <0.0001 | 392.91 | 383.18 | 402.88 |
| 3 years | 0.1928 | 0.0126 | 15.36 | <0.0001 | 355.66 | 346.83 | 364.71 |
| 4 years | 0.0694 | 0.0134 | 5.16 | <0.0001 | 314.36 | 305.87 | 323.08 |
| 5 years | Ref | 293.28 | 285.86 | 300.9 | |||
| Sex | |||||||
| Male | Ref | 371.88 | 364.04 | 379.89 | |||
| Female | −0.0023 | 0.0073 | −0.31 | 0.7528 | 371.03 | 363.8 | 378.41 |
| Race | |||||||
| White | Ref | 399.72 | 393.7 | 405.84 | |||
| Black | −0.1468 | 0.007 | −20.87 | <0.0001 | 345.16 | 339.43 | 351 |
| Hispanic | −0.0973 | 0.0196 | −4.95 | <0.0001 | 362.66 | 348.53 | 377.37 |
| Other | −0.0493 | 0.021 | −2.34 | 0.0191 | 380.48 | 364.62 | 397.04 |
| Age group | |||||||
| 21–30 | Ref | 364.95 | 356.14 | 373.98 | |||
| 31–40 | 0.0001 | 0.0101 | 0.01 | 0.9942 | 364.98 | 356.86 | 373.28 |
| 41–50 | 0.0258 | 0.0107 | 2.4 | 0.0162 | 374.51 | 366.08 | 383.12 |
| 51–64 | 0.0447 | 0.0103 | 4.32 | <0.0001 | 381.65 | 373.81 | 389.65 |
| Elixhauser comorbidities | |||||||
| Hypertension | −0.0415 | 0.0081 | −5.1 | <0.0001 | 379.25 | 371.33 | 387.34 |
| Diabetes | −0.0273 | 0.0093 | −2.94 | 0.0033 | 376.56 | 367.82 | 385.51 |
| Substance use | −0.0651 | 0.0127 | −5.11 | <0.0001 | 383.74 | 373.2 | 394.58 |
| Nicotine use | −0.1366 | 0.0081 | −16.87 | <0.0001 | 397.72 | 389.2 | 406.42 |
Note: This table presents a Poisson regression model showing that each additional year of prevention was associated with savings in dental care in 2019.
FIGURE 2Paid amounts by dental procedure groupings. This figure stratifies dental costs in the measurement year of 2019 by CDT procedure code groupings
FIGURE 3Average dental costs 2014–2019 based on years prevention between 2014 and 2018. This figure shows average dental costs for all years in the study to compare dental costs for the cohort over the entire study period
Characteristics of patients with emergency department visits for non‐traumatic dental conditions (ED‐NTDC), Oral surgeries, and dental‐related opioid prescriptions
| Covariates | ED NTDC | Oral surgery | Dental‐related opioid prescriptions | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients | Row % | Odds ratio | 95% CI ( | Patients | Row % | Odds ratio | 95% CI ( | Patients | Row% | Odds ratio | 95% CI ( | |
| Years prevention | (<0.0001) | (<0.0001) | (<0.0001) | |||||||||
| 0 years | 3512 | 5.5% | 4.62 | 3.95–5.40 | 27,787 | 44.0% | 6.16 | 5.85–6.48 | 11,675 | 20.3% | 5.11 | 4.72–5.54 |
| 1 year | 1298 | 4.0% | 3.23 | 2.75–3.80 | 10,152 | 31.9% | 3.82 | 3.61–4.03 | 4548 | 15.8% | 3.65 | 3.35–3.97 |
| 2 years | 766 | 2.8% | 2.51 | 2.12–2.98 | 5983 | 23.6% | 2.63 | 2.49–2.79 | 2798 | 12.1% | 2.79 | 2.56–3.05 |
| 3 years | 386 | 2.0% | 1.59 | 1.32–1.91 | 3732 | 18.4% | 1.89 | 1.78–2.01 | 1637 | 9.1% | 1.97 | 1.80–2.17 |
| 4 years | 251 | 1.3% | 1.31 | 1.08–1.60 | 2511 | 13.7% | 1.38 | 1.30–1.48 | 1042 | 5.9% | 1.44 | 1.30–1.59 |
| 5 years | 176 | 0.7% | ref | 1911 | 9.8% | ref | 712 | 4.0% | ref | |||
| Sex | (0.0006) | (0.1687) | (<0.0001) | |||||||||
| Male | 1793 | 2.9% | ref | 16,635 | 29.0% | ref | 5920 | 11.2% | ref | |||
| Female | 4596 | 3.9% | 1.11 | 1.04–1.18 | 35,441 | 29.8% | 1.02 | 0.99–1.04 | 16,492 | 15.3% | 1.32 | 1.28–1.36 |
| Race | (<0.0001) | (<0.0001) | (<0.0001) | |||||||||
| White | 3516 | 3.4% | ref | 29,072 | 28.0% | ref | 11,388 | 12.3% | ref | |||
| Black | 2292 | 3.8% | 1.15 | 1.09–1.22 | 17,668 | 31.7% | 1.05 | 1.03–1.08 | 8458 | 16.5% | 1.32 | 1.28–1.36 |
| Hispanic | 107 | 1.6% | 0.83 | 0.68–1.01 | 1057 | 20.5% | 0.88 | 0.82–0.95 | 517 | 9.3% | 1.12 | 1.02–1.23 |
| Other | 494 | 44.1% | 0.56 | 0.42–0.74 | 4279 | 37.3% | 0.98 | 0.91–1.07 | 2049 | 17.9% | 1.01 | 0.90–1.14 |
| Age groups | (<0.0001) | (0.6245) | (<0.0001) | |||||||||
| 21–30 | 1578 | 4.5% | ref | 9682 | 27.3% | ref | 5322 | 16.7% | ref | |||
| 31–40 | 2077 | 4.4% | 0.83 | 0.77–0.89 | 13,358 | 28.6% | 0.99 | 0.96–1.02 | 6598 | 15.8% | 0.85 | 0.82–0.89 |
| 41–50 | 1361 | 3.4% | 0.62 | 0.57–0.67 | 11,230 | 29.7% | 1.01 | 0.97–1.04 | 4675 | 13.4% | 0.72 | 0.68–0.75 |
| 51–64 | 1373 | 2.3% | 0.36 | 0.33–0.39 | 17,806 | 31.7% | 0.99 | 0.96–1.03 | 5817 | 11.1% | 0.53 | 0.50–0.55 |
| Elixhauser comorbidities | ||||||||||||
| Hypertension | 2505 | 3.9% | 1.32 | 1.24–1.41 | 19,954 | 31.4% | 1.06 | 1.03–1.08 | 8069 | 12.7% | 1.13 | 1.09–1.17 |
| Diabetes | 1252 | 3.7% | 1.13 | 1.05–1.21 | 10,874 | 32.1% | 1.10 | 1.07–1.13 | 4117 | 12.1% | 1.00 | 0.96–1.04 |
| Substance use | 926 | 6.8% | 1.29 | 1.19–1.39 | 5200 | 38.1% | 1.18 | 1.14–1.23 | 2116 | 15.5% | 1.00 | 0.95–1.06 |
| Nicotine use | 3269 | 7.1% | 2.76 | 2.61–2.91 | 16,985 | 37.1% | 1.40 | 1.36–1.43 | 7806 | 17.1% | 1.52 | 1.47–1.57 |
| Model: Logistic regression | ||||||||||||
Note: This table is based on three logistic regression models where the dependent variable is either ED‐NTDC, Oral Surgery or Dental Opioids respectively as seen in the measurement year, 2019. Row % refers to the percent of patients in each category. For instance, 5.5% of 0 year prevention patients had an ED‐NTDC visit in 2019.
Probability of being in each prevention group
| Reference group = 0 year prevention | |||||
|---|---|---|---|---|---|
| Covariates | 1‐year prevention | 2‐year prevention | 3‐year prevention | 4‐year prevention | 5‐year prevention |
| Sex (Ref = Male) | |||||
| Female | 1.17 (1.14–1.21) | 1.17 (1.14–1.21) | 1.11 (1.07–1.14) | 1.05 (1.01–1.09) | 0.9 (0.87–0.93) |
| Race (Ref = White) | |||||
| Black | 0.86 (0.84–0.89) | 0.77 (0.74–0.79) | 0.7 (0.68–0.72) | 0.59 (0.57–0.62) | 0.49 (0.47–0.51) |
| Hispanic | 1.36 (1.24–1.49) | 1.46 (1.33–1.6) | 1.42 (1.29–1.57) | 1.38 (1.25–1.52) | 1.23 (1.11–1.36) |
| Other | 1.22 (1.09–1.35) | 1.29 (1.16–1.44) | 1.31 (1.17–1.47) | 1.31 (1.17–1.47) | 1.45 (1.3–1.62) |
| Age group (Ref = 21–30) | |||||
| 31–40 | 0.73 (0.7–0.76) | 0.74 (0.71–0.77) | 0.73 (0.69–0.76) | 0.79 (0.76–0.84) | 0.84 (0.8–0.88) |
| 41–50 | 0.63 (0.6–0.66) | 0.64 (0.61–0.68) | 0.7 (0.66–0.73) | 0.82 (0.78–0.87) | 0.97 (0.92–1.02) |
| 51–64 | 0.48 (0.46–0.5) | 0.47 (0.45–0.5) | 0.52 (0.5–0.55) | 0.65 (0.62–0.69) | 0.83 (0.79–0.88) |
| Elixhauser comorbidities | |||||
| Hypertension | 0.93 (0.9–0.96) | 0.91 (0.88–0.95) | 0.87 (0.84–0.91) | 0.81 (0.77–0.84) | 0.76 (0.73–0.79) |
| Diabetes | 0.94 (0.9–0.98) | 0.91 (0.87–0.95) | 0.85 (0.81–0.89) | 0.86 (0.82–0.9) | 0.77 (0.73–0.81) |
| Substance use | 0.93 (0.89–0.98) | 0.79 (0.74–0.83) | 0.68 (0.64–0.73) | 0.5 (0.46–0.54) | 0.35 (0.31–0.38) |
| Nicotine Use | 0.82 (0.8–0.85) | 0.69 (0.67–0.71) | 0.54 (0.52–0.57) | 0.42 (0.4–0.44) | 0.3 (0.28–0.31) |
Note: For this table, we ran a generalized logit model to determine how sociodemographic, health and lifestyle factors contribute to the probability that a patient falls into specific prevention categories as measured by number years prevention in the lookback period.
Average dental costs by years prevention
| 0 year prevention | 1 year prevention | 2 years prevention | 3 years prevention | 4 years prevention | 5 years prevention | |
|---|---|---|---|---|---|---|
| All patients | $464.08 | $417.35 | $382.04 | $332.69 | $294.48 | $263.22 |
| Sex | ||||||
| Male | $488.79 | $420.83 | $374.64 | $316.14 | $280.10 | $249.44 |
| Female | $451.76 | $415.99 | $384.99 | $339.66 | $301.50 | $271.62 |
| Race | ||||||
| White | $508.48 | $440.33 | $394.77 | $337.65 | $293.34 | $257.39 |
| Black | $395.29 | $363.71 | $346.90 | $306.39 | $289.75 | $279.43 |
| Hispanic | $446.85 | $328.84 | $365.88 | $372.14 | $315.81 | $285.60 |
| Other | $452.52 | $420.18 | $344.71 | $334.65 | $255.18 | $257.68 |
| Age group | ||||||
| 21–30 | $418.67 | $406.70 | $375.36 | $323.19 | $297.50 | $261.44 |
| 31–40 | $453.12 | $408.32 | $380.18 | $325.64 | $275.56 | $241.72 |
| 41–50 | $490.01 | $421.65 | $379.93 | $342.83 | $295.61 | $250.96 |
| 51–64 | $475.13 | $433.87 | $392.86 | $340.96 | $309.27 | $290.82 |
Note: This table presents the average dental costs by the number of years of prevention in total and stratified by sex, race, and age group.